ArticleCancer biotherapy & radiopharmaceuticals2022

Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium Therapies.

Diane S Abou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.